Free Trial
NASDAQ:SXTP

60 Degrees Pharmaceuticals (SXTP) Stock Price, News & Analysis

$0.19
+0.01 (+6.62%)
(As of 09:29 AM ET)
Today's Range
$0.19
$0.22
50-Day Range
$0.18
$0.35
52-Week Range
$0.17
$2.29
Volume
13.58 million shs
Average Volume
2.29 million shs
Market Capitalization
$2.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.40

60 Degrees Pharmaceuticals MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
1,258.2% Upside
$2.40 Price Target
Short Interest
Healthy
2.96% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.45mentions of 60 Degrees Pharmaceuticals in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.56) to ($0.11) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.59 out of 5 stars

SXTP stock logo

About 60 Degrees Pharmaceuticals Stock (NASDAQ:SXTP)

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is based in Washington, District Of Columbia.

SXTP Stock Price History

SXTP Stock News Headlines

(XS2531438351.SG)
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Why Is 60 Degrees (SXTP) Stock Up 56% Today?
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
See More Headlines
Receive SXTP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 60 Degrees Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/15/2024
Today
7/25/2024
Next Earnings (Estimated)
8/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SXTP
Fax
N/A
Employees
3
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.40
High Stock Price Target
$2.40
Low Stock Price Target
$2.40
Potential Upside/Downside
+1,258.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-3,770,000.00
Pretax Margin
-848.39%

Debt

Sales & Book Value

Annual Sales
$250,000.00
Book Value
($0.87) per share

Miscellaneous

Free Float
10,952,000
Market Cap
$2.16 million
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Geoffrey Stuart Dow (Age 50)
    Chairman, CEO & President
    Comp: $125.56k
  • Mr. Tyrone Miller (Age 49)
    CFO & Treasurer
    Comp: $135.63k
  • Dr. Bryan Smith (Age 58)
    Chief Medical Officer
  • Ms. Kristen Landon (Age 57)
    Chief Commercial Officer
  • Ms. Jennifer Herz
    Director

SXTP Stock Analysis - Frequently Asked Questions

How have SXTP shares performed this year?

60 Degrees Pharmaceuticals' stock was trading at $1.02 at the beginning of the year. Since then, SXTP shares have decreased by 82.7% and is now trading at $0.1767.
View the best growth stocks for 2024 here
.

How were 60 Degrees Pharmaceuticals' earnings last quarter?

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) posted its earnings results on Wednesday, May, 15th. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.19. The business had revenue of $0.08 million for the quarter.

When did 60 Degrees Pharmaceuticals IPO?

60 Degrees Pharmaceuticals (SXTP) raised $7 million in an initial public offering on Wednesday, July 12th 2023. The company issued 1,400,000 shares at a price of $5.30 per share. WallachBeth Capital LLC served as the underwriter for the IPO.

Who are 60 Degrees Pharmaceuticals' major shareholders?

60 Degrees Pharmaceuticals' top institutional investors include Central Bank & Trust Co. (1.37%).

How do I buy shares of 60 Degrees Pharmaceuticals?

Shares of SXTP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SXTP) was last updated on 7/25/2024 by MarketBeat.com Staff

From Our Partners